Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

Hirofumi Yasue(Kumamoto City Hospital), Kōichi Nakao(Kanazawa Seiryo University), Masashi Mukoyama(Omuta hospital), Kazuhiro Okumura(Chiba Cancer Center), Hayakazu Sumida(The University of Tokyo), Kiyotaka Kugiyama(University of Yamanashi), Michihiro Yoshimura(Jikei University School of Medicine), Michihisa Jougasaki(Kagoshima Medical Center), K Kikuta(Kumamoto University), Hisao Ogawa(Kumamoto University Hospital)
Circulation
July 1, 1994
10.1161/01.cir.90.1.195
Cited by 1,343

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755